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Novel circRNA discovery in sheep 
shows evidence of high backsplice 
junction conservation
Endika Varela‑Martínez1, Giulia I. Corsi2, Christian Anthon2, Jan Gorodkin2* & 
Begoña M. Jugo1*
Circular RNAs (circRNAs) are covalently closed circular non‑coding RNAs. Due to their structure, 
circRNAs are more stable and have longer half‑lives than linear RNAs making them good candidates 
for disease biomarkers. Despite the scientific relevance of these molecules, the study of circRNAs in 
non‑model organisms is still in its infancy. Here, we analyse total RNA‑seq data to identify circRNAs 
in sheep from peripheral blood mononuclear cells (PBMCs) and parietal lobe cortex. Out of 2510 
and 3403 circRNAs detected in parietal lobe cortex and in PBMCs, a total of 1379 novel circRNAs 
were discovered. Remarkably, around 63% of all detected circRNAs were found to be completely 
homologous to a circRNA annotated in human. Functional enrichment analysis was conducted for 
both tissues based on GO terms and KEGG pathways. The enriched terms suggest an important role 
of circRNAs from encephalon in synaptic functions and the involvement of circRNAs from PBMCs in 
basic immune system functions. In addition to this, we investigated the role of circRNAs in repetitive 
vaccination experiments via differential expression analysis and did not detect any significant 
relationship. At last, our results support both the miRNA sponge and the miRNA shuttle functions 
of CDR1‑AS in sheep brain. To our knowledge, this is the first study on circRNA annotation in sheep 
PBMCs or parietal lobe cortex samples.
Circular RNAs (circRNAs) are a new class of covalently closed circular non-coding RNAs, formed when a splice 
donor and upstream acceptor from a linear RNA are linked together, a process also called  backsplicing1. Due to 
their circular structure, circRNAs are more stable, resistant to RNAse R and have longer half-lives than linear 
 RNAs2, making them good candidates for disease biomarkers. Despite being discovered long ago, with the first 
circular molecules (viroids) revealed by electron microscopy in  19763 and the first endogenous circRNA originat-
ing from the DCC tumour suppressor reported in humans in  19914, for a long time circRNAs were thought to be 
low abundance products derived from splicing  errors5. With the recent increase in high-throughput sequencing 
studies, it was shown that these molecules are more common than initially thought and that some of them have 
important roles in multiple  pathways6,7. The exact mechanism of circularization is not totally understood, but 
multiple factors have been related. It has been shown that circRNA biogenesis is positively correlated by RNA 
polymerase II elongation  rate8. In addition, multiple reports have shown that reverse complementary sequences 
in the flanking introns of the backspliced exons brings under close proximity the splice  sites9, allowing for the 
canonical spliceosomal machinery to be employed. Furthermore, RNA binding proteins such as Quaking (QKI), 
muscleblind (MBL) and fused in sarcoma (FUS) have also been reported to promote circRNA  biogenesis9.
Although the biological function of most circRNAs remains unknown, some circRNAs have been shown to 
contain clusters of miRNA binding sites that function as miRNA sponges (e.g., the circRNAs related to CDR1 
and SRY sequester miR-7 and miR-138, respectively)10. Thus, circRNAs may interfere in the usual miRNA-mRNA 
binding procedures. Other circRNAs have been shown to contain sequences that can act as internal ribosome 
entry sites (IRESes), such as circ-ZNF60911, thus can potentially code for proteins. However, their actual transla-
tion in vivo remains to be probed. Last, circRNAs can regulate a number of processes via protein-binding activity 
(e.g., the circ-FOXO3 forms a ternary complex with p21 and CDK2)12.
Recent reports have associated circRNA expression with multiple diseases and it has opened a new field for 
diagnosis and treatment. It has been shown that circRNA levels increase with age in brain, but the same has been 
shown in age-associated neurological disorders such as Alzheimer’s disease and Parkinson’s  disease13. In addition 
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to evidence of circRNAs playing a role in diseases such as atherosclerotic vascular disease risk, osteoarthritis and 
diabetes, it has been shown dysregulated expression of circRNAs in multiple types of cancer, including colorectal 
cancer, hepatocellular carcinoma and breast cancer, among  others14.
More recently, many circRNAs have been reported to be expressed abnormally and play important roles in 
the progression of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus or multiple 
 sclerosis15. Thus, circRNAs may not only serve as potential biomarkers but also act as immune regulators an offer 
potential opportunities for therapy.
Non-living vaccine antigens, especially purified or recombinant subunit vaccines, are often poorly immuno-
genic and require additional components to help stimulate protective immunity based on antibodies and effec-
tor T cell functions. These additional components, termed adjuvants, are added to vaccines to achieve a better 
protection, with the aluminium-based ones (especially aluminium hydroxide) being some of the most widely 
employed adjuvants in human and animal vaccines. Despite its widespread use and its probed safety record, the 
adjuvant’s mechanism of action is not fully understood.
Recently, some concerns regarding the safety of aluminium adjuvants has been raised, due to the possibility for 
aluminium adjuvants to reach distant organs such as spleen or brain after a long-term exposition. It was shown 
that after intramuscular injection of the aluminium adjuvant in mice, the material was translocated at a very 
slow rate in normal conditions to draining lymph nodes (DNL) and thereafter was detected as associated with 
phagocytes in blood and  spleen16. In addition, several studies have addressed the translocation of aluminium to 
the  brain16–18. However, this remains a subject with much controversy in the scientific community and there is 
no complete agreement regarding the translocation and biopersistence of this  material17,19,20.
In sheep, a form of the autoimmune/autoinflammatory syndrome induced by aluminium-adjuvants has been 
described as linked to repetitive inoculation with aluminium-containing  vaccines21. In this species, a number 
of circRNAs were previously identified from RNA sequencing data. Li et al. detected 6133 and 10,226 circRNAs 
in prenatal and postnatal muscle and pituitary glands of sheep,  respectively13,14. Interestingly, they observed an 
association of some circRNAs with economically important traits, such as the growth and development of muscle 
related signaling pathways in the first tissue and the regulation of hormone secretion in the second. In addition 
to this, the same group identified 9231 circRNAs differentially expressed in the estrus and anestrus pituitary 
system of  sheep15. Last, 886 circRNAs were detected in the skeletal muscle by Cao et al., and some of them were 
reported to be involved in muscle cell development and signaling  pathway16. Characterizing the circRNA profiles 
of specific tissues and cell types is a promising way to reveal functional properties of circRNAs.
Until now, there has been no study trying to address the functional role of circRNAs in aluminium adjuvancy 
through total RNA sequencing data analysis, nor attempts of annotating circRNAs in sheep peripheral blood 
mononuclear cells (PBMCs) or parietal lobe cortex samples. In this work the circRNAs of these two tissues will 
be characterized and their expression in animals with different adjuvancy treatments assessed. Characterizing 
how circRNAs are expressed in different tissues can improve our understanding of the sheep transcriptome and 
analysing their expression in vaccinated or adjuvanted animals could add information on the role of circRNAs 
in the immune response to aluminium adjuvants.
Results
CircRNAs characterization and distribution in encephalon and PBMCs. Total RNA-seq data was 
produced from RNA samples extracted from encephalon and PBMCs. The data have been previously used for in 
depth differential expression  analyses22,23 and it has been re-analysed for circRNA annotation. Two bioinformat-
ics tools,  Segemehl24 and  DCC25, were selected for circRNA identification, which resulted in 12,475 and 60,375 
candidate circRNAs in encephalon and 19,611 and 63,138 candidate circRNAs in PBMC samples by segemehl 
and DCC, respectively. Out of all the circRNAs detected in the encephalon, 4996 had concordant coordinates 
in both tools. After filtering circRNAs based on their abundance and expression patterns among samples (see 
“Material and methods”), 2510 circRNAs were selected for subsequent analyses. In PBMCs, 10,414 circRNAs 
were concordant between tools. After filtering, 3403 circRNAs were retained for further analysis. Details about 
filtered circRNAs are available as Supplementary Data S1 and S2 for encephalon and PBMCs, respectively. The 
naming of circRNAs in each tissue list was performed by assigning sequential unique numeric identifiers. From 
the 2510 and 3403 circRNAs detected in encephalon and PBMCs, 1236 were present concordantly in both tissues 
(Fig. 1). The counts from DCC were taken as reference abundance values.
In the available literature a number of studies have described the principal characteristics of circRNAs in 
human and  mouse10,26. In our sheep data, in both tissues, we observe that the longer the chromosome, the more 
circRNAs are detected (Supplementary Fig. S1), and that the circRNAs are most commonly formed by two 
or three exons, being those composed of two exons the most prevalent ones (Supplementary Fig. S1). This is 
in accordance with what was previously described in other  species10. A representation of the location of each 
circRNA in the reference genome is given in Supplementary Fig. S2 for encephalon and Supplementary Fig. S3 
for PBMCs.
Out of the 2510 candidate circRNAs detected in encephalon, 2372 overlap with 1642 annotated sheep genes. 
Of those circRNAs that originated from an annotated gene, 1927 were concordant with an annotated exon–intron 
boundary in both ends, while in the other cases, despite the overlap with an annotated gene, at least one end was 
not concordant with an annotated exon–intron boundary. Concerning the 3403 circRNAs detected in PBMCs, 
3249 were found to originate from 2006 annotated sheep genes. Of these, 2597 were concordant with an anno-
tated exon–intron boundary in both ends. In some cases, the cause of the discrepancy between the annotated 
exon–intron boundaries and the circRNA backspliced junctions could be explained by the incomplete state of 
the sheep gene annotation. The majority of genes host only one circRNA in both tissues (Supplementary Fig. S1).
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Sheep circRNAs are conserved. CircRNAs have been shown to be tissue specific and to be evolutionary 
 conserved27. The circRNAs detected in this study were compared to others previously identified in other tissues 
(pituitary gland and longissimus dorsi muscle) in sheep. Notably, only 175 circRNAs were consistently detected 
in all tissues, including ours (Fig. 2). Such low concordance is in agreement with other studies, which showed 
that the expression of circRNAs is tissue-dependent8. In addition, our results showed that 421 and 841 circRNAs 
were exclusive to the encephalon and PBMCs data, respectively, while the overlap between the two sets is com-
posed of 117 circRNAs (Fig. 2).
In addition to this, the detected circRNAs were compared to the human circRNAs annotated in  CIRCpedia28. 
First, sheep circRNA coordinates were translated to human ones with the UCSC liftOver  tool29 and classified 
based on their backsplice junction conservation. Out of the 2510 detected circRNAs in encephalon, 52 splice sites 
coordinates could not be lifted. For the rest, nearly all had at least one reported human circRNA utilizing one of 
the splice sites. A total of 1606 (63.98%) circRNAs were completely homologous to a human circRNA (Fig. 3a). 
Figure 1.  Venn diagram with the number of circRNAs detected in each tissue after filtering for a minimum 
expression in at least three samples.
Figure 2.  UpSet plot with the comparison of detected circRNAs in different studies. Encephalon and PBMCs 
refers to the circRNAs detected in this study, while Cunyuan_P (pituitary gland), Xiaoyue (pituitary gland), 
Cunyuan_M (longissimus dorsi muscle) and Cao (longissimus dorsi muscle) refers to the circRNAs detected 
 in45–48, respectively. Cells filled with a dot indicate the circRNA is in the corresponding database, while empty 
cells indicate that the circRNA is not present in the corresponding database. In red the circRNAs that are 
exclusively expressed in one database and in orange the circRNAs common to all databases. Intersections with 
less than 30 elements were removed for visualization purposes.
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In PBMCs, out of the 3403 detected circRNAs, 93 splice sites coordinates were not lifted to human, while 2114 
(62.12%) circRNAs were found to be completely homologous to a human circRNA (Fig. 3b).
Given that circRNAs include exons of coding genes, sheep circRNAs completely homologous to a human 
one but lacking a gene annotation in sheep were also screened for possible corresponding genes annotated in 
human (Supplementary Table S1).
Enrichment analysis. A functional enrichment analysis was conducted with g:Profiler30 on the  GO31 and 
 KEGG32 databases for both tissues, by considering the terms annotated for the parental genes of the detected 
circRNAs and after setting as background all the genes expressed in the corresponding tissue. Terms with an 
FDR less than 0.05 were selected as significant. The enriched GO terms are represented as networks in Supple-
Figure 3.  Bar plot with the result of the conservation analysis. In the x-axis the different categories described in 
“Material and methods” and in the y-axis the number of circRNAs in each category. (a) Encephalon; (b) PBMCs.
Figure 4.  Sub-network from enriched GO terms by g:Profiler in encephalon and visualized in Cytoscape after 
clustering with Autoannotate. Node size correspond to number of genes expressed from the term; edge size 
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mentary Fig. S4 and S5. Selected highly connected sub-networks of interest are shown in Figs. 4 and 5. The 20 
most enriched KEGG pathways are shown in Fig. 6a,b, for encephalon and PBMCs, respectively. Among the GO 
terms significantly enriched in encephalon, there are a number of terms related to synapse regulation, presynap-
tic endocytosis, behaviour, brain development and myelination, while among the KEGG pathways glutamatergic 
synapse, dopaminergic synapse and serotonergic synapse were enriched, suggesting an important role for some 
circRNAs in synaptic functions. Instead, in PBMCs, we retrieved GO terms related to B- and T-cell proliferation, 
T-cell differentiation, activation and regulation of immune response and neutrophil degranulation. In both tis-
sues, the KEGG T-cell receptor signaling pathway and B-cell receptor signaling pathway were enriched, suggest-
ing that some circRNAs may be involved in basic immune system functions.
circRNAs acting as sponges. To identify circRNAs which could function as miRNA sponges, we com-
pared all 2510 (encephalon) and 3403 (PBMCs) predicted circRNAs with clusters of miRNA binding sites 
reported by Pan et al.33 in the human genome, a dataset that comprises a total of 3673 predicted sponges for 1250 
miRNAs. Out of 3 (encephalon) and 4 (PBMCs) sheep circRNAs overlapping one or more candidate sponges-
miRNA pairs, we filtered out those entries for which the predicted sponged miRNA does not have a homologous 
pre-miRNA in sheep. As a result, in the encephalon tissue we identified 1 circRNA (circRNA4960) overlap-
ping predicted sponges for two miRNAs (miR-7 and miR-1224), while in PBMCs we retained two circRNAs, 
circRNA2342, which overlaps predicted sponges for miR-409, miR-383, miR-370, miR-369 and miR-212, and 
circRNA8181 for miR-124 (Supplementary Table  S2). Then circRNA-target-miRNA pairs were screened for 
miRNA binding sites in both human and sheep circRNA sequences with  RIsearch234. After removing overlap-
ping binding sites as described in Pan et al.33, 44 and 65 binding sites were respectively found on circRNA4960 
for miR-7 and miR-1224. Although the sheep circRNA4960 is shorter than the corresponding cluster of miRNA 
binding sites detected in human for miR-7 and miR-1224, the per-base binding sites ratio is higher in sheep, 
further underlying a possible functional role of this molecule in the sheep brain.
One of the most well characterized circRNAs in brain is the one related to the CDR1  gene35. Although CDR1 
is not annotated in sheep, blasting the human sequence of this gene against the sheep reference genome results 
in a single hit, matching a region of circRNA4960, detected in our encephalon samples. We lifted the coordinates 
Figure 5.  Sub-network from enriched GO terms by g:Profiler in PBMCs and visualized in Cytoscape after 
clustering with Autoannotate. Node size correspond to number of genes expressed from the term; edge size 
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of the sheep backsplice junctions (sheep genome version Oar_3.1) to the human genome (version hg38) with 
the UCSC liftOver  tool29 and found that circRNA4960 is homologous to the human CDR1-AS. Interestingly, 
circRNA4960 was one of the most expressed in our cortex samples (Supplementary Table S3). Among the highly 
expressed circRNAs detected in encephalon other two were homologous to previously characterized human 
circRNAs, circRNA4266 and circRNA4357, which originate from HOMER1 and ZNF609 genes, respectively.
In addition, recent studies have shown that miR-671 has sufficient complementarity with CDR1-AS36. Inter-
estingly, the binding pattern of miR-671 in sheep is identical to the human one and includes 13 canonical base 
pairs in the seed region, and only 1 mismatch over the entire sequence (Supplementary Fig. S6). Hence, our 
results support both the miRNA sponge and the miRNA shuttle functions previously proposed for CDR1-AS 
in brain and suggest a possible similar mechanism for miR-1224, which is reported as highly expressed in brain 
according to the Genotype-Tissue Expression (GTEx) Project v8.
The screening of circRNA-target-miRNA pairs identified in PBMCs showed that miRNA binding sites are 
scattered far away from one another over both the exonic and the much longer intronic regions of circRNA2342 
and circRNA8181, with few bindings overlapping with the clusters of miRNA binding sites identified in human, 
hence we could not infer any sponge activity for these circRNAs. The complete list of binding sites identified 
for sheep circRNA-miRNA pairs in both encephalon and PBMCs candidate circRNA sponges is available in 
Supplementary Table S2.
No differential expression due to repetitive vaccination. Our preliminary analysis of transcripts 
expression showed that the adjuvant sample 116-E derived from the encephalon tissue was an outlier, thus it 
was removed prior differential expression analysis. A PCA showing clusters of samples is shown in Supplemen-
tary Fig. S7. Differential expression analysis was performed with the R package  DESeq237. We did not detect 
any differentially expressed circRNA in any comparison after considering an adjusted p-value < 0.05 as cut-off. 
We also performed differential expression analysis normalizing the data as spliced reads per billion mapping 
(SRPBM), and by applying a Kruskal–Wallis test before correcting for multiple comparison with the Benjamini 
and Hochberg method. Also in this case, there were no significant differences between groups when an adjusted 
p-value < 0.05 was taken as cut-off.
For the PBMCs samples, the Harman R  package38 was applied to remove any batch effect in the data after 
normalizing by SRPBM. The PCA with the corrected data is shown in Supplementary Fig. S7. Then, both the 
limma  package39 and Kruskal–Wallis test were used to test for differential expression, but no circRNA was found 
to be differentially expressed in any comparison with an adjusted p-value < 0.05.
Discussion
CircRNAs are a novel class of endogenous non-coding RNAs with a cyclic structure formed through a covalent 
bind of a linear transcript. Lately, circRNAs have gained more attention due to their abundance, their expression 
levels in specific tissues and their involvement in different biological functions, particularly studied in human 
and  mouse40–42. However, studies on circRNAs in non-model organism such as sheep are still lacking, and there 
is no database recording such data yet. Here, we improved the annotation of circRNAs in sheep by adding a total 
of 1379 novel circRNAs, combined with relevant information such as conservation and potential function. This 
Figure 6.  The 20 most enriched KEGG pathways by g:Profiler. The bubble plots show in the Y-axis the 
enriched KEGG pathways, while in the X-axis the rich ratio is represented (rich ratio = amount of differentially 
expressed genes in the term/all genes included in the term). Size and colour of the bubble represent the number 
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set of robust circRNAs was selected from 2510 and 3403 circRNAs respectively detected in parietal lobe cortex 
and in PBMCs via in silico analysis of ribo-minus total RNA sequencing data. Most of the identified circRNAs 
in both tissues are from annotated genes, generally formed by two or three distinct exons, in agreement with 
what has been previously reported in human and mouse  data43. In addition, we observe that circRNAs are widely 
expressed in both of these tissues in sheep, which was somewhat expected since circRNAs are enriched in mam-
malian brain and human  PBMCs44.
Some circRNAs have a tissue-dependent or developmental stage-dependent expression  pattern8. The circR-
NAs detected in this study were compared to other sheep circRNA identified in pituitary  gland45,46 and in longis-
simus dorsi  muscle47,48. Only 175 circRNAs were detected in all tissues, while several hundreds of circRNAs were 
exclusive to each tissue. Furthermore, given that numerous circRNAs have exhibited evolutionary conservation 
between human and  mouse49, the circRNAs detected in this study were analysed for backsplice site conservation, 
by comparing them to the human circRNAs available in CIRCpedia. We found that 1606 (63.98%) and 2114 
(62.12%) sheep circRNAs have completely conserved backsplice sites between human and sheep in encephalon 
and PBMCs, respectively. Among the most expressed circRNAs, circRNA4266 and circRNA4357, in order origi-
nating from the HOMER1 and ZNF609 genes, had been previously characterized in other species. Consistent 
with this, it has been shown that the circRNA related to HOMER1 has a regulatory role in cell growth in human 
bronchial epithelial cells, as its silencing promotes cell  proliferation50. The circRNA originated from ZNF609 has 
been shown to adsorb miR-150-5p and to upregulate SP1 transcription factor, promoting the proliferation of 
nasopharyngeal carcinoma  cells51. In addition, this circRNA has been related to myoblast proliferation and the 
fact that its sequence includes an open reading frame and that a fraction of this circRNA is loaded into polysomes 
indicates that it may encode for  proteins11.
It was previously proposed that the binding activity between circRNAs and RNA binding proteins (RBPs) 
can have regulatory  effects52, which suggests that circRNAs can impact the same functional processes in which 
the corresponding linear host gene is involved. Under the assumption that the function of a circRNA may be 
associated with the known function of its parental gene, GO analysis indicated that the circRNAs identified in 
encephalon are related to synapse regulation, behaviour, learning process and brain development, while KEGG 
pathway analysis also related these circRNAs to synapses and to pathways implicated in cell proliferation such 
MAPK/ERK pathways, the last ones being previously linked to  circRNAs43. In contrast, in the PBMCs samples, 
GO terms associated with the immune system such as B- and T-cell proliferation, neutrophil degranulation, the 
MAPK cascade and the NF-κB signaling were enriched, as well as DNA methylation and histone modification, 
supporting the possibility that circRNAs could be related to epigenetic alterations, as previously  suggested53. In 
both tissues the B- and T-cell receptor signalling pathways were enriched, in addition to Fc epsilon RI signaling 
pathway, Th17 cell differentiation and platelet activation in PBMCs samples, indicating a potential functional 
role for circRNAs in the immune system response.
Then, we performed a differential expression analysis to find out if circRNAs could have a role in aluminium 
adjuvancy in vaccines. We did not detect any differentially expressed circRNAs in any of the two tissues, which 
indicates that circRNAs may not be connected with aluminium adjuvant effects. Despite this, it should be noted 
that no differential expression analysis software has been specifically designed to handle circRNA data, in which 
expression levels are generally lower compared to mRNA and are subjected to greater variability.
Moreover, we screened circRNAs for the presence of clusters of miRNA binding sites, following the concept 
that circRNAs can act as miRNA sponges. We report that the circRNA CDR1-AS, which corresponds to cir-
cRNA4960 in this study, contains numerous binding sites for miR-7 and miR-1224, both reported to be expressed 
in the mammalian brain. In agreement with our expectations, we observed that this circRNA is highly expressed 
only in our encephalon samples. In addition, recent studies have shown that miR-671 has sufficient comple-
mentarity with CDR1-AS to induce AGO2 endonucleolytic cleavage and, based on this, an alternative function 
for this circRNA molecule as miRNA shuttle system, releasing its miR-7 cargo upon binding with miR-671, has 
been  proposed36. It was shown that the binding sites for miR-671 were retained in sheep, supporting its role in 
cleavage by AGO2.
In conclusion, a number of circRNAs were identified in sheep encephalon and PBMCs samples, expanding 
our knowledge on the sheep transcriptome. Moreover, several GO terms and KEGG pathways showed that circR-
NAs may be involved with synapse regulation and cell proliferation in encephalon and with the immune system 
response and epigenetic modifications in PBMCs. Furthermore, we showed how circRNA functions associated 
with the presence of clusters of miRNA binding sites are conserved between sheep and human. This study is a 
first systematic analysis of circRNAs in sheep parietal lobe cortex and PBMC samples, and it is also a first study 
of the changes in circRNA expression profiles after an aluminium-based adjuvant vaccine inoculation schedule.
Material and methods
Ethics statement. All experimental procedures were approved and licensed by the Ethical Committee of the 
University of Zaragoza (ref: PI15/14). Requirements of the Spanish Policy for Animal Protection (RED53/2013) 
and the European Union Directive 2010/63 on protection of experimental animals were always fulfilled.
Datasets. The data samples used in this work have been previously used for in depth differential expression 
analyses and detailed information about the experimental design and sequencing can be found in the corre-
sponding articles for both tissues,  PBMCs22 and parietal lobe  cortex23. Briefly, healthy three-month-old Rasa 
Aragonesa pure breed lambs from a single pedigree flock, with the condition of not having undergone any kind 
of vaccination before the experiment, were selected to be placed in the experimental farm of the university of 
Zaragoza. After a period of two months to acclimatize to the new environment, all lambs were randomly distrib-
uted in different treatment groups, each consisting of 7 animals. One of the groups, from now on denominated 
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vaccine group (Vac), received a subcutaneous treatment with commercial vaccines based on aluminium hydrox-
ide adjuvant. Another group, denominated adjuvant group (Adj), received equivalent doses to the commercial 
vaccines of aluminium hydroxide only (Alhydrogel, CZ Veterinaria, Spain) diluted in phosphate-buffered saline 
(PBS). Finally, PBS was administered to the control group. Blood samples were taken at the start (before any vac-
cination) and at the end of the experiment, while for encephalon (parietal lobe cortex) only samples at the end 
were taken. In Table 1 there is a summary of the samples used for sequencing.
The complete experiment lasted 475 days, from February 2015 to June 2016. During that period of time, nine 
different vaccines were administered, which comprises a total of 19 inoculations throughout 16 different inocula-
tion dates. A total amount of 81.29 mg of Al per animal was given in the Vac and Adj groups. A detailed list of 
the commercial vaccines used in this study can be seen as supplementary material in a previous  publication22.
Out of all the animals, only 12 (four animals per group) and 6 (three animals per group at the start and at the 
end of the experiment) were selected for sequencing from encephalon and PBMCs, respectively. For both tissues, 
Illumina Total RNA-seq libraries were used and sequenced with a high sequencing depth.
CircRNA identification. First, a read quality filtering and trimming was performed with  Trimmomatic54 
[v0.38] using the following criteria: (1) adaptor removal with the “palindrome” mode for paired-end data; (2) 
trimming of bases from the start or end of a read if their quality dropped below a Phred value of 20; (3) trimming 
of reads if the average quality within a sliding window of five nucleotides fell below 20; and (4) read filtering if 
their length was sorter than 40.
For circRNA identification two tools were selected,  segemehl24 [v0.3.4] and  DCC25 [v0.4.7]. Before running 
segemehl, quality filtered reads were first aligned to the sheep reference genome (Oar_v3.1) with  HISAT255 
[v2.1.0]. The set of non-aligned reads from the previous step were used to detect circRNAs in segemehl with 
default parameters. In contrast, for DCC, the quality filtered reads were first aligned to the reference genome with 
STAR [v2.6.1d]56 following DCC author recommendations. Then, the chimeric.out.junction files from the previ-
ous alignments and a file with repetitive regions in the sheep genome downloaded from the UCSC table browser 
(RepeatMasker and Simple Repeats tracks) were passed to DCC. DCC was run with default parameters, except 
that we require a circRNA had to be expressed with one read in at least one sample to be reported. For further 
analysis, different filtering criteria were tested for the encephalon and PBMC tissues, as they were subjected to 
different experimental setups. In both tissues circRNAs needed a minimum of 2 read counts to be considered as 
expressed. In addition, in encephalon, circRNAs were required to be expressed at least in the same three samples 
in both tools, while in PBMCs they needed to be expressed at least in the same three samples from one group in 
both tools. The expression counts for the detected circRNAs and host genes were taken as reference from DCC, 
focusing mainly in exonic circRNAs for further analysis (still referring them as circRNAs throughout the text).
Conservation analysis. The main databases of circRNA annotation are focused on human, mouse, rat, 
zebrafish, fly and worm, being sheep circRNA data not submitted to any database to date. A literature search of 
articles in which circRNAs in sheep are detected and are given at least as supplementary material was done in 
an attempt to compare the circRNAs annotated in this study. Four studies focusing on two different tissues were 
found: two from the pituitary  gland45,46 and another two from the longissimus dorsi  muscle47,48.
Then, the detected circRNAs were compared to the ones annotated in  CIRCpedia28 for human. The following 
steps were performed:
1. The 5′ and 3′ flank coordinates of each circRNA found in sheep were converted to human coordinates with 
the USCS liftOver  tool29 with default parameters (min. ratio of remapped bases = 0.95).
2. The resulting coordinates were screened for overlap with human annotated circRNAs in CIRCpedia. Splice 
sites detected in ± 2 nt intervals around the putative human sites were considered homologous.
3. Different categories were assigned to each circRNA: “not-aligned”, the sheep coordinates were not translated 
to human with liftOver; “no homologous”, no human circRNA detected near both splice sites; “5′ site uti-
lized”, a human circRNA that only uses the 5′ splice site is detected; “3′ site utilized”, a human circRNA that 
Table 1.  Sample summary. a Same RNA sample obtained with a conventional TRIzol extraction method.
Treatment Time Samples
Encephalon
Adjuvant End (Tf) 114-E, 115-E, 116-E, 117-E
Vaccine End (Tf) 121-E, 122-E, 124-E, 126-E
Control End (Tf) 131-E, 135-E, 136-E, 137-E
PBMCs
Adjuvant
Start (T0) 121-A, 124-A, 125-A
End (Tf) 121-B, 124-B, 125-B, 125-Ba
Vaccine
Start (T0) 111-A, 114-A, 116-A
End (Tf) 111-B, 114-B, 116-B
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only uses the 3′ splice site is detected; “Both sites utilized”, both splice sites are used by different circRNAs 
in human; and “homologous”, a human circRNA using both splice sites is detected.
Enrichment analysis. The detected circRNAs whose origin was in an annotated gene were further analysed 
as follows. Gene enrichment analysis was conducted using the  GO31 and  KEGG32 databases in g:Profiler30. This 
tool computes p-values for enriched terms using a Fisher’s exact test and applies the Benjamini–Hochberg mul-
tiple test correction. The set of all expressed genes detected in the total RNA-seq libraries was set as background 
and related terms associated with the host genes of the circRNAs were tested for enrichment. Terms composed 
of more than 400 genes, due to limited interpretative value, or composed of less than 5 genes, due to the decrease 
in statistical power by multiple testing correction, were removed from the analysis. Those terms with an FDR 
less than 0.05 were selected for further analysis. For visualization purposes, the list of enriched GO term was 
further analysed with Cytoscape using EnrichmentMap and Autoannotate  plugins57. EnrichmentMap generates 
a network in which pathways are visualized as nodes connected between each other if they share many genes. 
Pathways with common genes often represent similar biological processes and are grouped together as sub-
networks. Clusters with less than 3 interconnected nodes were removed for visualization purposes.
circRNAs acting as miRNA sponges. A list of predicted clusters of miRNA binding sites previously 
reported in the human genome (hg19) was downloaded from Pan et  al.33. The genomic coordinates of each 
sponge candidate were converted to hg38 with liftOver (min. ratio of remapped bases = 0.95) and intersected 
with those of the circRNAs identified in this study, already lifted from the sheep reference genome to the human 
genome hg38 as explained above, with bedtools (min. fraction overlap = 75%). Results were then filtered by 
excluding sponges targeting miRNAs for which no high confidence orthologue sequence was reported in 
sheep according to  Ensembl58 (release 97). All human miRNAs hairpins were screened for similarity with the 
Oar3.1 genome with BLAST, requiring a minimum sequence identity of 90% on at least 95% of the hairpin. 
The sequences of the processed miRNAs were downloaded from  miRBase59 (Release 22.1) and the correspond-
ing sheep orthologous were extracted from the alignment provided by Ensembl. CircRNAs were screened for 
miRNA binding sites with  RIsearch234, using the following parameters: -s 1:8/6 -e -10 -l 20 -p2. In the same way 
we re-evaluated the clusters of miRNA binding sites identified in human and noticed almost no difference com-
pared to the binding sites previously reported (Supplementary Table S2). The same criteria were applied to find 
binding sites of miR-671 on the human CDR1-AS and on the corresponding sheep circRNA4960.
Differential expression analysis. For the encephalon samples, the differential expression analysis was per-
formed via two different methods. First, the analysis was done with  DESeq237, setting an adjusted p-value < 0.05 
as significance cut-off. An alternative method was also applied, given that DESeq2 is not designed to work on 
circRNA expression data. In this case, for normalization of the circRNA expression data, not only the circRNA 
counts were taken into consideration to calculate library sizes, but the total amount of reads aligned to the refer-
ence annotation was considered. The data was then normalized by SRPBM (Spliced Reads per Billion Mapped 
Reads)5. After normalization, a Kruskal–Wallis test was employed to check for differences between groups, and 
the resulting p-values were adjusted for multiple comparisons with the Benjamini and Hochberg method. An 
adjusted p-value < 0.05 was taken as significance cut-off to identify the differentially expressed circRNAs.
For the PBMC samples, a batch effect removal program, harman [v1.12.0]38, was applied after normalizing 
data by SRPBM. Then, the package  limma39 and the Kruskal–Wallis test were applied to check for differential 
expression. Those circRNAs with an adjusted p-value < 0.05 were taken as cut-off.
Data availability
RNA-seq data have been deposited in the NCBI Gene Expression Omnibus (GEO) database with experiment 
accession number GSE128597 for encephalon samples and GSE113899 for PBMCs samples.
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